Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/HML/archive/2026/2026-10-01/HML_2026-10-01.xml; October 2026; published 2026-10-01; acquired 2026-10-13T22:49:54.923639+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.
Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substances
- Magnesium oxide, Aspartate, amino acid chelate, Magnesium citrate
- Dosage form
- Cap 500 mg with magnesium aspartate 100 mg, magnesium amino acid chelate 100 mg and magnesium citrate 100 mg (345 mg elemental magnesium)
- Register
- New Zealand (PHARMAC)
- Status
- Funded